DBV Technologies: DBV Technologies S.A.: DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
Châtillon, France, February 25, 2025 DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clini...
Read full article »
DBV is a France-based biopharmaceutical company that develops and commercializes epicutaneous immunotherapy products for patients with food allergies.
Read more